Advertisement
News
Advertisement

Edwards Lifesciences goes after another set of Medtronic patents

Tue, 07/16/2013 - 1:35pm
Mass Device

Edwards Lifesciences wants a federal judge to invalidate a pair of patents covering nerve stimulation sensing technology owned by arch-rival Medtronic.

Edwards Lifesciences goes after another set of Medtronic patents

Edwards Lifesciences (NYSE:EW) wants a federal judge to rule that a pair of patents owned by arch-rival Medtronic (NYSE:MDT) are invalid because they aren't specific enough.

The patents – the so-called '741 patent for a "Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure" and the '829 patent for a "Method and system for nerve stimulation prior to and during a medical procedure – cover nerve stimulation technology.

Edwards and Medtronic have spent considerable time in courts around the world, each arguing that the other's transcatheter aortic valve implant infringes various patents.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading